Skip to content

PeriVeRie

Can VR-based perimetry accurately measure the peripheral visual field? - PeriVeRie

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON58450
Enrollment
64
Registered
2025-07-22
Start date
2026-04-13
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Visual field defects The visual field is everything a person can see when fixating on a point in space.

Interventions

Performing the Esterman visual field test on a CE-certified VR perimeter (Oculera VFA).

Sponsors

Universitair Medisch Centrum Groningen
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age = 18 years.Ability to understand instructions and complete the test correctly.For patients: clinically confirmed binocular peripheral VF defect (in visual rehabilitation).For healthy participants: no known ocular or neurological conditions (glasses or cataract surgery are not exclusion criteria, assessed with a questionnaire, F1a).

Exclusion criteria

Exclusion criteria: Severe cognitive, motor, or language impairments that prevent correct test execution.Visual acuity worse than 0.3 logMAR (corrected).Medical contraindications to the use of a VR-based device (e.g. epilepsy).For controls, an abnormal Esterman test result on repeated testing with the gold standard (Octopus).

Design outcomes

Primary

MeasureTime frame
Healthy participants: the proportion of false-positive outcomes (detection of visual field defects where none is present according to the reference standard).Patients with known VF defects: the proportion of false-negative outcomes (failure to detect existing visual field defects) 

Secondary

MeasureTime frame
the spatial agreement of VF defect locations for the VR perimeter compared with the bowl-shaped perimeter, expressed using the Dice score (the Dice score is the proportion of visual field loss that is correctly matched in location relative to the total amount of loss).User-friendliness of each device, assessed via a custom-designed questionnaire (F1b), after completion of each test.Test completeness of the VR-based perimeter device: number of incomplete or technically failed assessments.Executability: number of participants unable to complete the VR-perimetry test.

Countries

Netherlands

Contacts

Public ContactJ. Koopman

Koninklijke Visio

jankoopman@visio.org0885855700

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Jun 11, 2026